Search alternatives:
significant treatment » significant agreement (Expand Search), significant enrichment (Expand Search), significant threat (Expand Search)
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
treatment decrease » treatment decreased (Expand Search), treatments decreased (Expand Search), treatment increases (Expand Search)
decrease risk » increased risk (Expand Search), increases risk (Expand Search), disease risk (Expand Search)
Showing 161 - 180 results of 32,577 for search '(( significant decrease risk ) OR ( significant treatment decrease ))', query time: 0.57s Refine Results
  1. 161
    Primary care providers’ and nurses’ knowledge, attitudes, and skills regarding LTBI management–major themes throughout the care cascade.

    Primary care providers’ and nurses’ knowledge, attitudes, and skills regarding LTBI management–major themes throughout the care cascade. by Daria Szkwarko (4318921)

    Published 2022
    Subjects:
    Save to List
    Saved in:
  2. 162
    Demographics of primary care providers and nurses interviewed (n = 24).

    Demographics of primary care providers and nurses interviewed (n = 24). by Daria Szkwarko (4318921)

    Published 2022
    Subjects:
    Save to List
    Saved in:
  3. 163
    Significantly Enriched Pathways.

    Significantly Enriched Pathways. by Jiyong Zhang (2498740)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  4. 164
    Both cis- and trans-cycles decrease in number upon treatment with auxin.

    Both cis- and trans-cycles decrease in number upon treatment with auxin. by Manu Aggarwal (15990691)

    Published 2023
    Save to List
    Saved in:
  5. 165
    Data at baseline and after 12 weeks of treatment with DAA therapy (n = 280).

    Data at baseline and after 12 weeks of treatment with DAA therapy (n = 280). by Phuong Nguyen Thi Thu (11503489)

    Published 2023
    Subjects:
    Save to List
    Saved in:
  6. 166
    Version 2 of the Cochrane risk-of-bias tool for randomized controlled trials.

    Version 2 of the Cochrane risk-of-bias tool for randomized controlled trials. by Solima Sabeel (9545738)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  7. 167
    Aripiprazole significantly decreases phosphorylated Src (Y416) levels in dHL-60 cells.

    Aripiprazole significantly decreases phosphorylated Src (Y416) levels in dHL-60 cells. by Courtney A. Swain (15170264)

    Published 2025
    Save to List
    Saved in:
  8. 168
    Motifs significantly enriched in decreased ATAC peaks relative to unchanged ATAC peaks at 30 minutes.

    Motifs significantly enriched in decreased ATAC peaks relative to unchanged ATAC peaks at 30 minutes. by Thomas G. Scott (4092892)

    Published 2024
    Save to List
    Saved in:
  9. 169
    Exercise is associated with a decrease in BMI.

    Exercise is associated with a decrease in BMI. by Stephanie Y. Yang (8384520)

    Published 2022
    Save to List
    Saved in:
  10. 170
    Analysis of Significantly Different ARGs and Resistance Mechanisms.

    Analysis of Significantly Different ARGs and Resistance Mechanisms. by Xu Jia (187142)

    Published 2025
    Save to List
    Saved in:
  11. 171
    Treatment with pan-PKC inhibitor Gö-6983 resulted in a non-significant decrease in <i>GRK6</i> promoter activity.

    Treatment with pan-PKC inhibitor Gö-6983 resulted in a non-significant decrease in <i>GRK6</i> promoter activity. by Maike Stegen (8578665)

    Published 2021
    Save to List
    Saved in:
  12. 172
    Lysosomal area is significantly decreased and lysosomal distribution is altered in FcRn KO podocytes compared to WT after treatment with immune complexes.

    Lysosomal area is significantly decreased and lysosomal distribution is altered in FcRn KO podocytes compared to WT after treatment with immune complexes. by George Haddad (470789)

    Published 2023
    Save to List
    Saved in:
  13. 173
    Groupings of statistically significantly associated proteins by their biological processes.

    Groupings of statistically significantly associated proteins by their biological processes. by Alish B. Palmos (5857379)

    Published 2022
    Save to List
    Saved in:
  14. 174
    Clinical features, co-morbidities, and treatment of patients with COVID-19 and MM.

    Clinical features, co-morbidities, and treatment of patients with COVID-19 and MM. by Sultan Mahmud (11414066)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  15. 175
    The flow chart of studies selecting.

    The flow chart of studies selecting. by Xin Liu (43569)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  16. 176
    Forest plot of the effect of high-dose TXA on transfusion rate.

    Forest plot of the effect of high-dose TXA on transfusion rate. by Xin Liu (43569)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  17. 177
    Forest plot of the effect of high-dose TXA on intraoperative blood loss.

    Forest plot of the effect of high-dose TXA on intraoperative blood loss. by Xin Liu (43569)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  18. 178
    Forest plot of the effect of high-dose TXA on operation time.

    Forest plot of the effect of high-dose TXA on operation time. by Xin Liu (43569)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  19. 179
    Characteristics of the included studies.

    Characteristics of the included studies. by Xin Liu (43569)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  20. 180
    Funnel plots for intraoperative blood loss.

    Funnel plots for intraoperative blood loss. by Xin Liu (43569)

    Published 2025
    Subjects:
    Save to List
    Saved in:

Search Tools: